The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment —
Continue reading »
mypharmacynews.com
Home »
The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment —
Continue reading »Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances
Continue reading »The SARS-CoV-2 coronavirus RNA genome structure was studied in detail by researchers from the University of Groningen, the International Institute
Continue reading »Hitting the sweet spot can make all the difference, especially for patients suffering from chronic sinus infection. New instructions for
Continue reading »In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia. These genetic discoveries raise
Continue reading »Most people get a blood pressure lowering benefit from eating less salt and the less you eat, the more you
Continue reading »A Purdue University-affiliated startup has created a platform aimed at treating relapse patients for cancers and other diseases by taking
Continue reading »No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and
Continue reading »Alzheimer’s disease (AD) is a devastating condition with no known cure. Existing drugs only alleviate symptoms. Given repeated and costly
Continue reading »People in the UK, US and China have a higher risk of dying early from conditions like cancer, heart disease
Continue reading »